BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11535528)

  • 1. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.
    Masood R; Cai J; Zheng T; Smith DL; Hinton DR; Gill PS
    Blood; 2001 Sep; 98(6):1904-13. PubMed ID: 11535528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
    Spiekermann K; Faber F; Voswinckel R; Hiddemann W
    Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Sakitani H; Iki K; Taniguchi S; Kitamura S; Konishi Y
    Mol Carcinog; 1999 Apr; 24(4):287-93. PubMed ID: 10326865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas.
    Langer I; Vertongen P; Perret J; Fontaine J; Atassi G; Robberecht P
    Med Pediatr Oncol; 2000 Jun; 34(6):386-93. PubMed ID: 10842244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway.
    Matsushita K; Motani R; Sakuta T; Yamaguchi N; Koga T; Matsuo K; Nagaoka S; Abeyama K; Maruyama I; Torii M
    J Dent Res; 2000 Aug; 79(8):1596-603. PubMed ID: 11023281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes.
    Nomura M; Yamagishi S; Harada S; Hayashi Y; Yamashima T; Yamashita J; Yamamoto H
    J Biol Chem; 1995 Nov; 270(47):28316-24. PubMed ID: 7499331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.
    Graeven U; Fiedler W; Karpinski S; Ergün S; Kilic N; Rodeck U; Schmiegel W; Hossfeld DK
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):621-9. PubMed ID: 10541969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
    Masood R; Cai J; Zheng T; Smith DL; Naidu Y; Gill PS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):979-84. PubMed ID: 9023368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
    Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
    Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis.
    Baek JH; Jang JE; Kang CM; Chung HY; Kim ND; Kim KW
    Oncogene; 2000 Sep; 19(40):4621-31. PubMed ID: 11030151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
    Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
    Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
    Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.